<?xml version="1.0" encoding="iso-8859-1" standalone="no"?>
<!DOCTYPE GmsArticle SYSTEM "http://www.egms.de/dtd/2.0.34/GmsArticle.dtd">
<GmsArticle xmlns:xlink="http://www.w3.org/1999/xlink">
  <MetaData>
    <Identifier>26rhk108</Identifier>
    <IdentifierDoi>10.3205/26rhk108</IdentifierDoi>
    <IdentifierUrn>urn:nbn:de:0183-26rhk1087</IdentifierUrn>
    <ArticleType>Meeting Abstract</ArticleType>
    <TitleGroup>
      <Title language="de">Vom Long-COVID-Verdacht mit psychiatrischer Manifestation zur seltenen autoinflammatorischen Erkrankung</Title>
    </TitleGroup>
    <CreatorList>
      <Creator>
        <PersonNames>
          <Lastname>B&#246;hm</Lastname>
          <LastnameHeading>B&#246;hm</LastnameHeading>
          <Firstname>Svea</Firstname>
          <Initials>S</Initials>
        </PersonNames>
        <Address>
          <Affiliation>P&#228;diatrische Rheumatologie und Infektiologie, Klinik f&#252;r Allgemeinp&#228;diatrie Freiburg, P&#228;diatrische Rheumatologie, Freiburg, Deutschland</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Kaluza</Lastname>
          <LastnameHeading>Kaluza</LastnameHeading>
          <Firstname>Elke</Firstname>
          <Initials>E</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Neurop&#228;diatrie Heidelberg, Uniklinikum Heidelberg, Neurop&#228;diatrie, Heidelberg, Deutschland</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Ehl</Lastname>
          <LastnameHeading>Ehl</LastnameHeading>
          <Firstname>Stephan</Firstname>
          <Initials>S</Initials>
        </PersonNames>
        <Address>
          <Affiliation>CCI Centrum f&#252;r Chronische Immundefizienz, Kinderklinik Freiburg, P&#228;diatrische Immunologie, Freiburg, Deutschland</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
    </CreatorList>
    <PublisherList>
      <Publisher>
        <Corporation>
          <Corporatename>German Medical Science GMS Publishing House</Corporatename>
        </Corporation>
        <Address>D&#252;sseldorf</Address>
      </Publisher>
    </PublisherList>
    <SubjectGroup>
      <SubjectheadingDDB>610</SubjectheadingDDB>
    </SubjectGroup>
    <DatePublishedList>
      <DatePublished>20260909</DatePublished>
    </DatePublishedList>
    <Language>germ</Language>
    <License license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
      <AltText language="en">This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License.</AltText>
      <AltText language="de">Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung).</AltText>
    </License>
    <SourceGroup>
      <Meeting>
        <MeetingId>M0656</MeetingId>
        <MeetingSequence>108</MeetingSequence>
        <MeetingCorporation>Deutsche Gesellschaft f&#252;r Rheumatologie</MeetingCorporation>
        <MeetingCorporation>Deutsche Gesellschaft f&#252;r Orthop&#228;dische Rheumatologie</MeetingCorporation>
        <MeetingCorporation>Gesellschaft f&#252;r Kinder- und Jugendrheumatologie</MeetingCorporation>
        <MeetingName>54. Kongress der Deutschen Gesellschaft f&#252;r Rheumatologie und Klinische Immunologie (DGRh), 36. Jahrestagung der Gesellschaft f&#252;r Kinder- und Jugendrheumatologie (GKJR), 40. Jahrestagung der Deutschen Gesellschaft f&#252;r Orthop&#228;dische Rheumatologie (DGORh)</MeetingName>
        <MeetingTitle>Deutscher Rheumatologiekongress 2026</MeetingTitle>
        <MeetingSession>Der besondere Fall</MeetingSession>
        <MeetingCity>Leipzig</MeetingCity>
        <MeetingDate>
          <DateFrom>20260909</DateFrom>
          <DateTo>20260912</DateTo>
        </MeetingDate>
      </Meeting>
    </SourceGroup>
    <ArticleNo>FA.24</ArticleNo>
  </MetaData>
  <OrigData>
    <TextBlock name="Text" linked="yes">
      <MainHeadline>Text</MainHeadline><Pgraph><Mark1>Vorgeschichte:</Mark1> Die A20-Haploinsuffizienz (HA20) ist eine autoinflammatorische Erkrankung, die durch heterozygote Loss-of-Function-Mutationen im TNFAIP3-Gen verursacht wird und zu einer &#220;beraktivierung des NF-&#954;B-Signalwegs f&#252;hrt <TextLink reference="1"></TextLink>. Die Manifestation erfolgt meist im Kindesalter und ist durch rezidivierende mukokutane Ulzerationen, Fieber, gastrointestinale Beschwerden, Arthralgien, Lymphadenopathie sowie autoimmune Zytopenien gekennzeichnet <TextLink reference="2"></TextLink>, <TextLink reference="3"></TextLink>. Als Therapie kommen h&#228;ufig TNF-&#945;- und IL-1-Inhibitoren zum Einsatz, jedoch bestehen bislang keine einheitlichen diagnostischen Kriterien oder standardisierten Therapieempfehlungen <TextLink reference="4"></TextLink>.</Pgraph><Pgraph><Mark1>Leitsymptome bei Krankheitsmanifestation:</Mark1> Eine 16-j&#228;hrige Patientin stellte sich in einer Long-COVID-Ambulanz mit ausgepr&#228;gter Fatigue vor. Zudem bestanden waren f&#252;r die Patientin subjektiv am eingeschr&#228;nktesten diffuse Ganzk&#246;rperschmerzen, die eine Teilnahme am Alltag kaum mehr m&#246;glich gemacht haben. Au&#223;erdem zeigten sich &#252;ber die Zeit neuropsychiatrische Symptome im Sinne einer Depression und akustischen Pseudohalluzinationen, die einen Aufenthalt in der Kinder-&#47;und Jugendpsychiatrie notwendig machten. In der rheumatologisch&#47;immunologischen Anamnese fiel dann eine erh&#246;hte Infektanf&#228;lligkeit mit Minor-Infektionen, eine chronische Sinusitis, sowie schwere und langwierige rezidivierende orale und genitale Ulzerationen auf. Zudem bestand eine cervical betone Lymphadenopathie.</Pgraph><Pgraph><Mark1>Diagnostik:</Mark1> Im Rahmen einer genetischen Einzel-Exom-Analyse wurde eine Variante unklarer Signifikanz (VUS) im TNFAIP3-Gen identifiziert. Laborchemisch zeigten sich Hinweise auf eine milde inflammatorische Aktivit&#228;t (IgG 1730 mg&#47;dL, BSG 25 mm&#47;h, l&#246;slicher IL-2-Rezeptor 730 U&#47;mL). Die Immunph&#228;notypisierung ergab einen erh&#246;hten Anteil seneszenter CD57&#43;&#47;CD8&#43; T-Zellen sowie einen gesteigerten Anteil transitionaler B-Zellen. Bildgebende Untersuchungen (kraniales MRT, abdominale Sonographie) waren unauff&#228;llig.</Pgraph><Pgraph><Mark1>Therapie:</Mark1> Unter Therapie mit einem TNF-&#945;-Inhibitor (Adalimumab) kam es zu einem raschen R&#252;ckgang der mukokutanen Ulzerationen, Verbesserung der Ganzk&#246;rper-Schmerzen sowie zu einer deutlichen Besserung der neuro-psychiatrischen Symptomatik. Erg&#228;nzend erfolgte eine psychosomatische station&#228;re Behandlung ohne Einsatz psychopharmakologischer Medikation.</Pgraph><Pgraph><Mark1>Weiterer Verlauf: </Mark1>Drei Monate nach Therapiebeginn war eine regelm&#228;&#223;ige Teilnahme am Schulunterricht bei guter Alltagsfunktion wieder m&#246;glich. Die Lebensqualit&#228;t der Patientin ist deutlich gebessert.</Pgraph></TextBlock>
    <References linked="yes">
      <Reference refNo="1">
        <RefAuthor>Zhou Q</RefAuthor>
        <RefAuthor>Wang H</RefAuthor>
        <RefAuthor>Schwartz DM</RefAuthor>
        <RefAuthor>Stoffels M</RefAuthor>
        <RefAuthor>Park YH</RefAuthor>
        <RefAuthor>Zhang Y</RefAuthor>
        <RefAuthor>Yang D</RefAuthor>
        <RefAuthor>Demirkaya E</RefAuthor>
        <RefAuthor>Takeuchi M</RefAuthor>
        <RefAuthor>Tsai WL</RefAuthor>
        <RefAuthor>Lyons JJ</RefAuthor>
        <RefAuthor>Yu X</RefAuthor>
        <RefAuthor>Ouyang C</RefAuthor>
        <RefAuthor>Chen C</RefAuthor>
        <RefAuthor>Chin DT</RefAuthor>
        <RefAuthor>Zaal K</RefAuthor>
        <RefAuthor>Chandrasekharappa SC</RefAuthor>
        <RefAuthor>Hanson EP</RefAuthor>
        <RefAuthor>Yu Z</RefAuthor>
        <RefAuthor>Mullikin JC</RefAuthor>
        <RefAuthor>Hasni SA</RefAuthor>
        <RefAuthor>Wertz IE</RefAuthor>
        <RefAuthor>Ombrello AK</RefAuthor>
        <RefAuthor>Stone DL</RefAuthor>
        <RefAuthor>Hoffmann P</RefAuthor>
        <RefAuthor>Jones A</RefAuthor>
        <RefAuthor>Barham BK</RefAuthor>
        <RefAuthor>Leavis HL</RefAuthor>
        <RefAuthor>van Royen-Kerkof A</RefAuthor>
        <RefAuthor>Sibley C</RefAuthor>
        <RefAuthor>Batu ED</RefAuthor>
        <RefAuthor>G&#252;l A</RefAuthor>
        <RefAuthor>Siegel RM</RefAuthor>
        <RefAuthor>Boehm M</RefAuthor>
        <RefAuthor>Milner JD</RefAuthor>
        <RefAuthor>Ozen S</RefAuthor>
        <RefAuthor>Gadina M</RefAuthor>
        <RefAuthor>Chae J</RefAuthor>
        <RefAuthor>Laxer RM</RefAuthor>
        <RefAuthor>Kastner DL</RefAuthor>
        <RefAuthor>Aksentijevich I</RefAuthor>
        <RefTitle>Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>Nat Genet</RefJournal>
        <RefPage>67-73</RefPage>
        <RefTotal>Zhou Q, Wang H, Schwartz DM, Stoffels M, Park YH, Zhang Y, Yang D, Demirkaya E, Takeuchi M, Tsai WL, Lyons JJ, Yu X, Ouyang C, Chen C, Chin DT, Zaal K, Chandrasekharappa SC, Hanson EP, Yu Z, Mullikin JC, Hasni SA, Wertz IE, Ombrello AK, Stone DL, Hoffmann P, Jones A, Barham BK, Leavis HL, van Royen-Kerkof A, Sibley C, Batu ED, G&#252;l A, Siegel RM, Boehm M, Milner JD, Ozen S, Gadina M, Chae J, Laxer RM, Kastner DL, Aksentijevich I. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet. 2016 Jan;48(1):67-73. DOI: 10.1038&#47;ng.3459</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1038&#47;ng.3459</RefLink>
      </Reference>
      <Reference refNo="2">
        <RefAuthor>Aeschlimann FA</RefAuthor>
        <RefAuthor>Batu ED</RefAuthor>
        <RefAuthor>Canna SW</RefAuthor>
        <RefAuthor>Go E</RefAuthor>
        <RefAuthor>G&#252;l A</RefAuthor>
        <RefAuthor>Hoffmann P</RefAuthor>
        <RefAuthor>Leavis HL</RefAuthor>
        <RefAuthor>Ozen S</RefAuthor>
        <RefAuthor>Schwartz DM</RefAuthor>
        <RefAuthor>Stone DL</RefAuthor>
        <RefAuthor>van Royen-Kerkof A</RefAuthor>
        <RefAuthor>Kastner DL</RefAuthor>
        <RefAuthor>Aksentijevich I</RefAuthor>
        <RefAuthor>Laxer RM</RefAuthor>
        <RefTitle>A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Ann Rheum Dis</RefJournal>
        <RefPage>728-735</RefPage>
        <RefTotal>Aeschlimann FA, Batu ED, Canna SW, Go E, G&#252;l A, Hoffmann P, Leavis HL, Ozen S, Schwartz DM, Stone DL, van Royen-Kerkof A, Kastner DL, Aksentijevich I, Laxer RM. A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease. Ann Rheum Dis. 2018 May;77(5):728-735. DOI: 10.1136&#47;annrheumdis-2017-212403</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1136&#47;annrheumdis-2017-212403</RefLink>
      </Reference>
      <Reference refNo="3">
        <RefAuthor>Deuitch NT</RefAuthor>
        <RefAuthor>Schwartz DM</RefAuthor>
        <RefAuthor>Aksentijevich I</RefAuthor>
        <RefTitle>Haploinsufficiency of A20</RefTitle>
        <RefYear>1993&#8211;2026</RefYear>
        <RefBookTitle>GeneReviews&#174;</RefBookTitle>
        <RefPage></RefPage>
        <RefTotal>Deuitch NT, Schwartz DM, Aksentijevich I. Haploinsufficiency of A20. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews&#174;. Seattle (WA): University of Washington, Seattle; 1993&#8211;2026.</RefTotal>
      </Reference>
      <Reference refNo="4">
        <RefAuthor>He T</RefAuthor>
        <RefAuthor>Wang J</RefAuthor>
        <RefAuthor>Carpio Tumba M</RefAuthor>
        <RefAuthor>Wang S</RefAuthor>
        <RefAuthor>Luo Y</RefAuthor>
        <RefAuthor>Chen J</RefAuthor>
        <RefAuthor>Li G</RefAuthor>
        <RefAuthor>Shu Z</RefAuthor>
        <RefAuthor>Zhang S</RefAuthor>
        <RefAuthor>Stone DL</RefAuthor>
        <RefAuthor>Huang Y</RefAuthor>
        <RefAuthor>Lv Q</RefAuthor>
        <RefAuthor>Xiong W</RefAuthor>
        <RefAuthor>Wang J</RefAuthor>
        <RefAuthor>Yu Z</RefAuthor>
        <RefAuthor>Cuff CV</RefAuthor>
        <RefAuthor>Kairis E</RefAuthor>
        <RefAuthor>Kethri A</RefAuthor>
        <RefAuthor>Towheed A</RefAuthor>
        <RefAuthor>Goyette K</RefAuthor>
        <RefAuthor>Karri U</RefAuthor>
        <RefAuthor>Wang J</RefAuthor>
        <RefAuthor>Liu C</RefAuthor>
        <RefAuthor>Romeo T</RefAuthor>
        <RefAuthor>Alsina L</RefAuthor>
        <RefAuthor>Rosenberg DL</RefAuthor>
        <RefAuthor>Clemente D</RefAuthor>
        <RefAuthor>L&#243;pez-Robledillo JC</RefAuthor>
        <RefAuthor>Rong Z</RefAuthor>
        <RefAuthor>Zhao X</RefAuthor>
        <RefAuthor>Jiang L</RefAuthor>
        <RefAuthor>Aldave-Becerra JC</RefAuthor>
        <RefAuthor>Mu&#241;oz-Urribarri AB</RefAuthor>
        <RefAuthor>Oommen PT</RefAuthor>
        <RefAuthor>Campbell-Stokes P</RefAuthor>
        <RefAuthor>Zhu M</RefAuthor>
        <RefAuthor>Liu P</RefAuthor>
        <RefAuthor>Guo L</RefAuthor>
        <RefAuthor>Xu Y</RefAuthor>
        <RefAuthor>Yu Z</RefAuthor>
        <RefAuthor>Tong H</RefAuthor>
        <RefAuthor>Qiu X</RefAuthor>
        <RefAuthor>Zhang Y</RefAuthor>
        <RefAuthor>Chen H</RefAuthor>
        <RefAuthor>Zhang C</RefAuthor>
        <RefAuthor>Ou J</RefAuthor>
        <RefAuthor>Liu C</RefAuthor>
        <RefAuthor>Liu J</RefAuthor>
        <RefAuthor>Shen Y</RefAuthor>
        <RefAuthor>Cao J</RefAuthor>
        <RefAuthor>Zhang X</RefAuthor>
        <RefAuthor>Yang K</RefAuthor>
        <RefAuthor>Bao Y</RefAuthor>
        <RefAuthor>Li Z</RefAuthor>
        <RefAuthor>Cao J</RefAuthor>
        <RefAuthor>Duan Y</RefAuthor>
        <RefAuthor>Liu F</RefAuthor>
        <RefAuthor>Shi B</RefAuthor>
        <RefAuthor>Sun M</RefAuthor>
        <RefAuthor>Ma L</RefAuthor>
        <RefAuthor>Chen Y</RefAuthor>
        <RefAuthor>Yang W</RefAuthor>
        <RefAuthor>Han X</RefAuthor>
        <RefAuthor>Ma S</RefAuthor>
        <RefAuthor>Luo J</RefAuthor>
        <RefAuthor>Gu W</RefAuthor>
        <RefAuthor>Yu G</RefAuthor>
        <RefAuthor>Shi W</RefAuthor>
        <RefAuthor>Zhao R</RefAuthor>
        <RefAuthor>Sun L</RefAuthor>
        <RefAuthor>Li W</RefAuthor>
        <RefAuthor>An Y</RefAuthor>
        <RefAuthor>Tang X</RefAuthor>
        <RefAuthor>Zhao X</RefAuthor>
        <RefAuthor>Han T</RefAuthor>
        <RefAuthor>Ma J</RefAuthor>
        <RefAuthor>Li Y</RefAuthor>
        <RefAuthor>Piao Y</RefAuthor>
        <RefAuthor>Sun F</RefAuthor>
        <RefAuthor>Zhang D</RefAuthor>
        <RefAuthor>Yin M</RefAuthor>
        <RefAuthor>Zheng S</RefAuthor>
        <RefAuthor>Li T</RefAuthor>
        <RefAuthor>Niu H</RefAuthor>
        <RefAuthor>Lin L</RefAuthor>
        <RefAuthor>Mei S</RefAuthor>
        <RefAuthor>Zhou F</RefAuthor>
        <RefAuthor>Yang S</RefAuthor>
        <RefAuthor>Li D</RefAuthor>
        <RefAuthor>Yan M</RefAuthor>
        <RefAuthor>Zeng H</RefAuthor>
        <RefAuthor>Zeng P</RefAuthor>
        <RefAuthor>Zheng W</RefAuthor>
        <RefAuthor>Li X</RefAuthor>
        <RefAuthor>Li X</RefAuthor>
        <RefAuthor>Liu Y</RefAuthor>
        <RefAuthor>Huang L</RefAuthor>
        <RefAuthor>Yu H</RefAuthor>
        <RefAuthor>Fan Z</RefAuthor>
        <RefAuthor>Shen M</RefAuthor>
        <RefAuthor>Lu M</RefAuthor>
        <RefAuthor>Fang Z</RefAuthor>
        <RefAuthor>Rimland CA</RefAuthor>
        <RefAuthor>Song H</RefAuthor>
        <RefAuthor>Peterson LW</RefAuthor>
        <RefAuthor>Yousuf Al-Nesf MA</RefAuthor>
        <RefAuthor>Aqel S</RefAuthor>
        <RefAuthor>Mudawi DS</RefAuthor>
        <RefAuthor>Raje N</RefAuthor>
        <RefAuthor>Slowik V</RefAuthor>
        <RefAuthor>Harris JG</RefAuthor>
        <RefAuthor>Snyder B</RefAuthor>
        <RefAuthor>Scheffler-Mendoza S</RefAuthor>
        <RefAuthor>Yamazaki-Nakashimada MA</RefAuthor>
        <RefAuthor>Cooper MA</RefAuthor>
        <RefAuthor>Lau YL</RefAuthor>
        <RefAuthor>Cetin Gedik K</RefAuthor>
        <RefAuthor>Wang W</RefAuthor>
        <RefAuthor>Ying W</RefAuthor>
        <RefAuthor>Hou J</RefAuthor>
        <RefAuthor>Zhou Q</RefAuthor>
        <RefAuthor>Sun B</RefAuthor>
        <RefAuthor>Sun J</RefAuthor>
        <RefAuthor>Wang X</RefAuthor>
        <RefAuthor>Ombrello AK</RefAuthor>
        <RefAuthor>Huang Y</RefAuthor>
        <RefAuthor>Wu HL</RefAuthor>
        <RefAuthor>Sun L</RefAuthor>
        <RefAuthor>Mao H</RefAuthor>
        <RefAuthor>Yu X</RefAuthor>
        <RefAuthor>Liu Z</RefAuthor>
        <RefAuthor>Aksentijevich I</RefAuthor>
        <RefAuthor>Kastner DL</RefAuthor>
        <RefAuthor>Schwartz DM</RefAuthor>
        <RefAuthor>Yang J</RefAuthor>
        <RefAuthor>Zhou Q</RefAuthor>
        <RefTitle>Multicenter international cohort study of haploinsufficiency of A20 reveals novel genetic architecture and phenotypic evolution</RefTitle>
        <RefYear>2026</RefYear>
        <RefJournal>J Allergy Clin Immunol</RefJournal>
        <RefPage>1395-1410</RefPage>
        <RefTotal>He T, Wang J, Carpio Tumba M, Wang S, Luo Y, Chen J, Li G, Shu Z, Zhang S, Stone DL, Huang Y, Lv Q, Xiong W, Wang J, Yu Z, Cuff CV, Kairis E, Kethri A, Towheed A, Goyette K, Karri U, Wang J, Liu C, Romeo T, Alsina L, Rosenberg DL, Clemente D, L&#243;pez-Robledillo JC, Rong Z, Zhao X, Jiang L, Aldave-Becerra JC, Mu&#241;oz-Urribarri AB, Oommen PT, Campbell-Stokes P, Zhu M, Liu P, Guo L, Xu Y, Yu Z, Tong H, Qiu X, Zhang Y, Chen H, Zhang C, Ou J, Liu C, Liu J, Shen Y, Cao J, Zhang X, Yang K, Bao Y, Li Z, Cao J, Duan Y, Liu F, Shi B, Sun M, Ma L, Chen Y, Yang W, Han X, Ma S, Luo J, Gu W, Yu G, Shi W, Zhao R, Sun L, Li W, An Y, Tang X, Zhao X, Han T, Ma J, Li Y, Piao Y, Sun F, Zhang D, Yin M, Zheng S, Li T, Niu H, Lin L, Mei S, Zhou F, Yang S, Li D, Yan M, Zeng H, Zeng P, Zheng W, Li X, Li X, Liu Y, Huang L, Yu H, Fan Z, Shen M, Lu M, Fang Z, Rimland CA, Song H, Peterson LW, Yousuf Al-Nesf MA, Aqel S, Mudawi DS, Raje N, Slowik V, Harris JG, Snyder B, Scheffler-Mendoza S, Yamazaki-Nakashimada MA, Cooper MA, Lau YL, Cetin Gedik K, Wang W, Ying W, Hou J, Zhou Q, Sun B, Sun J, Wang X, Ombrello AK, Huang Y, Wu HL, Sun L, Mao H, Yu X, Liu Z, Aksentijevich I, Kastner DL, Schwartz DM, Yang J, Zhou Q. Multicenter international cohort study of haploinsufficiency of A20 reveals novel genetic architecture and phenotypic evolution. J Allergy Clin Immunol. 2026 Jun;157(6):1395-1410. DOI: 10.1016&#47;j.jaci.2026.02.002</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1016&#47;j.jaci.2026.02.002</RefLink>
      </Reference>
    </References>
    <Media>
      <Tables>
        <NoOfTables>0</NoOfTables>
      </Tables>
      <Figures>
        <NoOfPictures>0</NoOfPictures>
      </Figures>
      <InlineFigures>
        <NoOfPictures>0</NoOfPictures>
      </InlineFigures>
      <Attachments>
        <NoOfAttachments>0</NoOfAttachments>
      </Attachments>
    </Media>
  </OrigData>
</GmsArticle>